Fig. 1From: Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigsRepresentative gelshift assays of NF-kappaB in nuclear extracts from (a) and immuncytochemical detection of NF-kappB (b) in liver and intestine to establish suitability of gel shift assay and immunohistology in this model. Animals were treated with saline or LPS (2 mg/kg body weight) and killed after the indicated time to obtain liver and intestine tissue. Arrow denotes nuclear NF-kappaB stainingBack to article page